A team of researchers sought to determine the efficacy of psilocybin as an antidepressant compared with placebo or ...

Moonwalk will show their first data for their two major platform components: the EpiRead and EpiWrite technologies.

Future research could identify drugs that can target this newfound brain circuit to help treat a vast range of immune ...

A schematic diagram of the influenza virus, showing the surface proteins hemagglutinin (blue, peanut shaped) and ...

Leading oncology drug developers raise $67 million in funding to target cancer's vulnerability to oncogene overactivation.

Collaboration is designed to accelerate the clinical progression of the next generation of cell and exosome therapeutics.

Federico Mingozzi, PhD, joins Allison Keeler, PhD, on GEN Live to discuss the state of gene therapy and what they are looking forward to at the ASGCT meeting in May.

Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many ...

The Producer service offers customers a second option for accessing Asimov's technology for the cell and gene therapy ...

Researchers at the Karolinska Institute may have found a new way to treat obesity and related disorders by targeting the ...

A new study shows that an inhibitor called ESI1 could potentially treat multiple sclerosis and other conditions associated with demyelination.

Novartis has agreed to acquire Mariana Oncology for up to $1.75 billion, the companies said today, in a deal that would ...